User:Ci Mar-Gar/QASC

This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs
This page was last edited by 203.10.47.15 (talk | contribs) 10 years ago. (Update timer)

Finished writing a draft article? Are you ready to request an experienced editor review it for possible inclusion in Wikipedia? Submit your draft for review!

Quality in Acute Stroke Care(QASC) was a research trial demonstrating that acute stroke patients who received improved management of fever, sugar and swallowing reflects, were 16% more likely to be alive or independent three months after their stroke. The study has received much attention in the stroke research community following its publication in 2011 ^[1] given that its results showed the lowest Number Needed to Treat(NNT=6.4)compared to other proven treatments.

STUDY INVESTIGATORS The Trial was led by Prof Sandy Middleton, director of the Nursing Research Institute (link) from the Australian Catholic University (link)

BACKGROUND x THE TRIAL (STUDY DESIGN, RESULTS & CONCLUSION) cluster randomized controlled (CRCT)[1]

AFTER THE TRIAL

xx FURTHER READING Xx

EXTERNAL LINKS xx

References

^ Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. The Lancet. 2011;378 (9804):1699-706.

External links

example.com

[1] Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. The Lancet. 2011;378 (9804):1699-706.

[1]